Brief: First Patient Enrolled In Cynata’s Mend Clinical Trial
24/05/2021 13:17
May 24 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* FIRST PATIENT ENROLLED IN CYNATA’S MEND CLINICAL TRIAL
Source text for Eikon: ID:nGNX32LYzZ
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million